April 30th 2025
A seminar shares key observations and learnings from the first round of direct price negotiations.
FDA Grants Breakthrough Therapy Designation to Bispecific Antibody for Follicular Lymphoma
November 27th 2023AbbVie and Genmab will share commercial responsibilities in the United States and Japan for epcoritamab-bysp (Epkinly) for the treatment of adults with follicular lymphoma that is relapsed or refractory following treatment with two or more therapies.